
MederiAI is a company at the forefront of gastrointestinal (GI) diagnostics, leveraging AI and deep learning to analyze endoscopic pill footage. They provide healthcare professionals with near real-time analysis, enabling quicker and more accurate diagnoses. Key features include anomaly detection and localization within the GI tract, automated video summarization for efficiency, predictive diagnostics for enhanced decision-making, and early warning notifications for time-sensitive risks like blood detection. MederiAI also offers video comparison for tracking disease progression, a cleanliness scale per segment evaluation, and automatic report generation. Their business model likely involves SaaS or licensing of their AI diagnostic platform to healthcare providers.

MederiAI is a company at the forefront of gastrointestinal (GI) diagnostics, leveraging AI and deep learning to analyze endoscopic pill footage. They provide healthcare professionals with near real-time analysis, enabling quicker and more accurate diagnoses. Key features include anomaly detection and localization within the GI tract, automated video summarization for efficiency, predictive diagnostics for enhanced decision-making, and early warning notifications for time-sensitive risks like blood detection. MederiAI also offers video comparison for tracking disease progression, a cleanliness scale per segment evaluation, and automatic report generation. Their business model likely involves SaaS or licensing of their AI diagnostic platform to healthcare providers.
What they do: AI/deep‑learning platform for near‑real‑time analysis of capsule endoscopy (endoscopic pill) video.
Founded / HQ: Founded 2024; listed location Copenhagen, Hovedstaden, Denmark.
Latest funding: Convertible Note announced 2025-03-19; investors listed: Plug and Play, VITA Accelerator (amount undisclosed).
Key features: Anomaly detection and localization, early‑warning notifications, automated video summarization, cleanliness scoring per segment, automatic report generation, longitudinal video comparison.
Website: mederiai.com
Gastrointestinal diagnostics using capsule endoscopy video analysis.
2024
Biotechnology
Round lists two investors; money raised not disclosed.
“Participation by Plug and Play and VITA Accelerator (convertible note, 2025-03-19).”